Clinical Trial Update: Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and contraceptive efficacy of relugolix combination therapy in women with uterine fibroids or endometriosis at risk for preg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Uterine Fibroids

Drugs mentioned

• Relugolix combination therapy (Relugolix)

Snippet

Sponsor: Sumitomo Pharma Switzerland GmbH | Conditions: Contraception | Phase 3 | Status: ACTIVE_NOT_RECRUITING